Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
reAlpha Tech Corp. (AIRE)
NASDAQ:AIRE
RESEARCH TOOLSreports
Holding AIRE?
Track your performance easily
AIRE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $4.25
Previous Close$1.09
Volume79.75K
Average Volume (3M)66.09K
Market Cap
$49.99M
Enterprise Value$47.71M
Total Cash (Recent Filing)$7.08M
Total Debt (Recent Filing)$4.79M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Nov 12, 2024EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,864,503
10 Day Avg. Volume79,215
30 Day Avg. Volume66,094
Standard Deviation0.35
R-Squared0.16
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.12
Price to Sales (P/S)124.99
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue132.65
Enterprise Value/Gross Profit378.01
Enterprise Value/Ebitda-15.24
Forecast
1Y Price Target
$3.00Price Target Upside175.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
reAlpha Tech Corp. News
PremiumCompany Announcements
reAlpha Tech Corp. Reports Significant Revenue Growth
PremiumCompany Announcements
reAlpha Tech Corp. Achieves 440% Q3 Revenue Surge
PremiumCompany Announcements
reAlpha Tech Corp. Expands AI-Driven Real Estate InnovationsOptions Prices
Currently, No data available
---
Ownership Overview
69.56% Insiders
0.26% Mutual Funds
0.04% Other Institutional Investors
29.87% Public Companies and
Individual Investors
AIRE FAQ
What was reAlpha Tech Corp.’s price range in the past 12 months?
reAlpha Tech Corp. lowest stock price was $0.53 and its highest was $4.25 in the past 12 months.
What is reAlpha Tech Corp.’s market cap?
Currently, no data Available
When is reAlpha Tech Corp.’s upcoming earnings report date?
reAlpha Tech Corp.’s upcoming earnings report date is Nov 12, 2024 which is 11 days ago.
How were reAlpha Tech Corp.’s earnings last quarter?
reAlpha Tech Corp. released its earnings results on Apr 19, 2024. The company reported -$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.032.
Is reAlpha Tech Corp. overvalued?
According to Wall Street analysts reAlpha Tech Corp.’s price is currently Undervalued.
Does reAlpha Tech Corp. pay dividends?
reAlpha Tech Corp. does not currently pay dividends.
What is reAlpha Tech Corp.’s EPS estimate?
reAlpha Tech Corp.’s EPS estimate is -$0.03.
How many shares outstanding does reAlpha Tech Corp. have?
reAlpha Tech Corp. has 45,864,502 shares outstanding.
What happened to reAlpha Tech Corp.’s price movement after its last earnings report?
reAlpha Tech Corp. reported an EPS of -$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6%.
Which hedge fund is a major shareholder of reAlpha Tech Corp.?
Currently, no hedge funds are holding shares in AIRE
---
reAlpha Tech Corp. Stock Smart Score
Company Description
reAlpha Tech Corp.
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
---
AIRE Stock 12 Month Forecast
Average Price Target
$3.00
▲(175.23% Upside)
Technical Analysis
Best Analysts Covering AIRE
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+0.35%
reiterated a buy rating 10 days ago
Copying Allen Klee's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.35% per trade.
---